Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2025-01-02T20:53:16.539Z Has data issue: false hasContentIssue false
  • English
  • Français

Strategies for Prevention of Infection in Short-Duration Neutropenia

Published online by Cambridge University Press:  02 January 2015

Lynda Fenelon
Lynda Fenelon*
Affiliation:
St Vincent's Hospital, Dublin, Ireland
*
Department of Microbiology, St Vincent's Hospital, Elm Park, Dublin 4, Ireland
Get access Rights & Permissions [Opens in a new window]

Abstract

Although infection continues to be a major cause of morbidity and mortality in neutropenic patients, newer strategies have resulted in a shorter duration of neutropenia. The prime risk to patients with short-duration neutropenia (defined as neutropenia of less than 14 days) is bacterial infection, which is reduced by the administration of prophylactic antibiotics, and possibly by the use of clean food, sterile water, and protection against transmission of organisms from healthcare workers' hands.

Type
From the Fifth International Conference on the Prevention of Infection
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 8 , August 1998 , pp. 590 - 592
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Roilides, E, Pizzo, PA. Perspectives on the use of cytokines in the management of infectious complications of cancer. Clin Infect Dis 1993;17(suppl 2):S385–S389.Google Scholar
2. Gorin, NC, Coiffier, B, Hayat, M, Fouillard, L, Kuentz, M, Flesch, M, et al. Recombinant human granulocyte-macrophage colony-stimulating factor after high dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind, placebo-controlled trial. Blood 1992;80:1149–1157.Google Scholar
3. Reichman, BS, Seidman, AD, Crown, JPA, Heelan, R, Hakes, TB, Lebwohl, DE, et al. Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 1993;11:1943–1951.Google Scholar
4. Terpestra, W, Lowenberg, B. Application of myeloid growth factors in the treatment of acute myeloid leukaemia. Leukaemia 1997;11:315–327.CrossRefGoogle Scholar
5. Iwen, PC, Reed, EC, Armitage, JO, Bierman, PJ, Kessinger, A, Vose, JM, et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 1993;14:131–139.CrossRefGoogle ScholarPubMed
6. Kolbe, K, Domkin, D, Derigs, HG, Bhakdi, S, Huber, C, Aulitzky, WE. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997;19: 143–147.CrossRefGoogle ScholarPubMed
7. Wald, A, Leisenring, W, Von Burik, JO, Bowden, RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459–1466.CrossRefGoogle Scholar
8. Levine, AS, Siegal, SE, Schreiber, AD, Hauser, J, Preisler, HD, Goldstein, IM, et al. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukaemia. N Engl J Med 1973;288:477–483.Google Scholar
9. Buckner, CD, Clift, RA, Sanders, JE, Meyers, JD, Counts, GW, Farewell, VT, et al. Protective environment for marrow transplant recipients. Ann Intern Med 1978; 89:893–901.Google Scholar
10. Schimpff, SC, Greene, WH, Young, V, Fortner, CL, Jepson, A, Cusack, N, et al. Infection prevention in acute non-lymphocytic leukaemia. Laminar air flow room reverse isolation with oral non-absorbable antibiotic prophylaxis. Ann Intern Med 1975;82:351–358.Google Scholar
11. Bodey, GP, Johnston, D. Microbiological evaluation of protected environments during patient occupancy. Appl Microbiol 1971;22:828–836.Google Scholar
12. Barnes, RA, Rogers, TR. Control of an outbreak of nosocomial aspergillosis by laminar airflow isolation. J Hosp Infect 1989;14:89–94.CrossRefGoogle Scholar
13. Nauseef, WM, Maki, DG. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 1981;304:448–453.Google Scholar
14. Kruger, W, Stockschlader, M, Zander, AR. Transmission of rotavirus diarrhea in a bone marrow transplantation unit by a hospital worker. Bone Marrow Transplantation 1991;8:507–508. Letter.Google Scholar
15. Harrington, RD, Hooton, TM, Hackman, RC, Storch, GA, Osborne, B, Benson, A, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant centre. J Infect Dis 1992;165:987–993.CrossRefGoogle Scholar
16. Remington, JS, Schimpff, SC. Please don't eat the salads. N Engl J Med 1981;304:433–434.CrossRefGoogle ScholarPubMed
17. Ljungman, P, Hagglund, H, Bjorkstrand, B, Lonnqvist, B, Ringden, O. Peroperative teicoplanin for prevention of gram-positive infections in neu-tropenic patients with indwelling central venous catheters: a randomised controlled study. Support Care Cancer 1997;5:485–488.Google Scholar